Stock & Company Details
Repligen Corp. $RGEN
Price:
N/A
N/A
56M
$10B
52 Week High:
N/A
10 Day Average Volume:
N/A
223.31
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
RGEN technical indicators
Latest Repligen Corp. (RGEN) indicator readings as of 2026-10-09.
RGEN's 14-day RSI is 47.8, in neutral territory. At $173.88 it is trading 20.9% above its 200-day moving average of $143.85, and above its 50-day average of $173.19. Price sits in the middle of its Bollinger Bands ($162.44 to $198.78). ADX reads 31.1, indicating a trending market.
RGEN backtested strategy results
How 4 rule-based strategies performed on Repligen Corp. (RGEN) over recent history, last backtested 2026-09-08. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +115.7% | 43% | 14 | -23.8% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | -56.0% | 23% | 35 | -79.8% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | -15.6% | 42% | 26 | -48.4% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +30.1% | 57% | 21 | -24.0% |
Overview
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
Finance Bot
Ask your questions
Start by typing a question below.
